Patents Assigned to PANDION OPERATIONS, INC.
  • PANCREAS TARGETED THERAPEUTICS AND USES THEREOF
    Publication number: 20240132591
    Abstract: The disclosure relates to methods and compositions for treating Type 1 diabetes, such as compositions comprising an effector domain linked to a protein that binds to MAdCAM.
    Type: Application
    Filed: February 22, 2022
    Publication date: April 25, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Daniel RIOS, Kevin OTIPOBY, Joanne L. VINEY, Nathan HIGGINSON-SCOTT
  • IL-2 muteins and uses thereof
    Patent number: 11965008
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: April 23, 2024
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 11945852
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: July 26, 2021
    Date of Patent: April 2, 2024
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • MULTI-PARATOPIC ANTI-PD-1 ANTIBODIES AND USES THEREOF
    Publication number: 20240052034
    Abstract: Multi-paratopic polypeptides that can be used, for example, to modulate the activity of PD-1.
    Type: Application
    Filed: August 19, 2021
    Publication date: February 15, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Nathan HIGGINSON-SCOTT, Kevin Lewis OTIPOBY, Joanne L. VINEY, Salvatore ALIOTO, Lindsay J. EDWARDS
  • MADCAM TARGETED THERAPEUTICS AND USES THEREOF
    Publication number: 20240010722
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
    Type: Application
    Filed: November 18, 2021
    Publication date: January 11, 2024
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Nathan HIGGINSON-SCOTT, Joanne L. VINEY, Salvatore ALIOTO, Lindsay J. EDWARDS, Kevin Lewis OTIPOBY, Jyothsna VISWESWARAIAH
  • IL-2 muteins and uses thereof
    Patent number: 11779632
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: October 10, 2023
    Assignee: PANDION OPERATION, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • MAdCAM targeted immunotolerance
    Patent number: 11739146
    Abstract: Methods and compounds for conferring site-specific or local immune privilege, such as targeting to a cell expressing MAdCAM.
    Type: Grant
    Filed: May 20, 2020
    Date of Patent: August 29, 2023
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Kevin Lewis Otipoby, Jyothsna Visweswaraiah, Salvatore Alioto, Lindsay J. Edwards, Erik Sampson, Jacob Glanville, David Maurer, Sarah Ives, Christina Pettus, Lauren Schwimmer
  • TISSUE TARGETED IMMUNOTOLERANCE WITH PD-1 AGONISTS OR IL-2 MUTEINS
    Publication number: 20230235004
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Application
    Filed: February 19, 2021
    Publication date: July 27, 2023
    Applicant: PANDION OPERATIONS, INC.
    Inventors: Joanne L. VINEY, Nathan HIGGINSON-SCOTT, Kevin OTIPOBY, Daniel RIOS, Susmita BORTHAKUR, Salvatore ALIOTO, Lindsay EDWARDS
  • Targeted immunotolerance
    Patent number: 11466068
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: October 11, 2022
    Assignee: Pandion Operations, Inc.
    Inventors: Joanne L. Viney, Nathan Higginson-Scott
  • IL-2 muteins and uses thereof
    Patent number: 11091526
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: August 17, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • IL-2 muteins and uses thereof
    Patent number: 11091527
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: August 17, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby
  • Targeted immunotolerance
    Patent number: 10961310
    Abstract: Methods and compounds for conferring site-specific or local immune privilege.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: March 30, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Joanne L. Viney, Nathan Higginson-Scott, Micah Benson, Alan Crane
  • IL-2 muteins and uses thereof
    Patent number: 10946068
    Abstract: The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: March 16, 2021
    Assignee: PANDION OPERATIONS, INC.
    Inventors: Nathan Higginson-Scott, Joanne L. Viney, Jyothsna Visweswaraiah, Erik Robert Sampson, Kevin Lewis Otipoby